| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C27H33N3O5 |
| Molar mass | 479.577 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BMS-F is a chemical from theaminoalkylindole family invented byBristol-Myers Squibb around 1999,[1] that acts as a potent and selectiveagonist for thecannabinoid receptorCB2, with aKi of 8 nM at CB2 and 500x selectivity over the relatedCB1 receptor. It hasantiinflammatory effects and inhibits release ofTNF-α.[2][3]